A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors
Clinical trial NCT00816361 · COMPLETED
Trial details
- NCT number
- NCT00816361
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-09
- Primary completion
- 2012-09-11
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.